AN2 Therapeutics, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-277673
- Form type
- 10-Q
- CIK
- 0001880438
- Primary document
- https://www.sec.gov/Archives/edgar/data/1880438/000119312525277673/antx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AN2 Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-28.8M | - | - |
| Net Income | $-26.5M | - | - |
| Eps Basic | -0.88 | - | - |
| Eps Diluted | -0.88 | - | - |
| Cash And Equivalents | $18.0M | - | - |
| Total Assets | $67.2M | - | - |
| Total Liabilities | $6.9M | - | - |
| Shareholders Equity | $60.4M | - | - |
| Operating Cash Flow | $-24.6M | - | - |